-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Neutral on Sabra Health Care REIT, Lowers Price Target to $20

Benzinga·10/13/2026 21:23:05
語音播報
UBS analyst Michael Goldsmith maintains Sabra Health Care REIT (NASDAQ:SBRA) with a Neutral and lowers the price target from $21 to $20.